Clonality	O
of	O
isolated	B-cell_type
eosinophils	I-cell_type
in	O
the	O
hypereosinophilic	O
syndrome	O
.	O

The	O
idiopathic	O
hypereosinophilic	O
syndrome	O
(	O
IHES	O
)	O
is	O
a	O
rare	O
disorder	O
characterized	O
by	O
unexplained	O
,	O
persistent	O
eosinophilia	O
associated	O
with	O
multiple	O
organ	O
dysfunction	O
due	O
to	O
eosinophilic	O
tissue	O
infiltration	O
.	O

In	O
the	O
absence	O
of	O
karyotypic	O
abnormalities	O
,	O
there	O
is	O
no	O
specific	O
test	O
to	O
detect	O
clonal	O
eosinophilia	O
in	O
IHES	O
.	O

Analysis	O
of	O
X-chromosome	B-DNA
inactivation	O
patterns	O
can	O
be	O
used	O
to	O
determine	O
whether	O
proliferative	O
disorders	O
are	O
clonal	O
in	O
origin	O
.	O

Methylation	O
of	O
HpaII	B-DNA
and	I-DNA
Hha	I-DNA
I	I-DNA
sites	I-DNA
near	O
the	O
polymorphic	B-DNA
trinucleotide	I-DNA
repeat	I-DNA
of	O
the	O
human	B-DNA
androgen	I-DNA
receptor	I-DNA
gene	I-DNA
(	O
HUMARA	B-DNA
)	O
has	O
been	O
shown	O
to	O
correlate	O
with	O
X-inactivation	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
used	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
with	O
nested	O
primers	O
to	O
analyze	O
X-inactivation	O
patterns	O
of	O
the	O
HUMARA	B-DNA
loci	I-DNA
in	O
purified	B-cell_type
eosinophils	I-cell_type
from	O
female	O
patients	O
with	O
eosinophilia	O
.	O

Peripheral	B-cell_type
blood	I-cell_type
eosinophils	I-cell_type
were	O
isolated	O
by	O
their	O
autofluoresence	O
using	O
flow	O
cytometric	O
sorting	O
.	O

Eosinophils	B-cell_type
purified	O
from	O
a	O
female	O
patient	O
presenting	O
with	O
IHES	O
were	O
found	O
to	O
show	O
a	O
clonal	O
pattern	O
of	O
X-inactivation	O
.	O

Eosinophil-depleted	B-cell_type
leukocytes	I-cell_type
from	O
this	O
patient	O
were	O
polyclonal	O
by	O
HUMARA	B-DNA
analysis	O
,	O
thus	O
excluding	O
skewedness	O
of	O
random	O
X-inactivation	O
.	O

After	O
corticosteroid	O
suppression	O
of	O
her	O
blood	O
eosinophilia	O
,	O
a	O
clonal	O
population	O
of	O
eosinophils	B-cell_type
could	O
no	O
longer	O
be	O
detected	O
in	O
purified	B-cell_type
eosinophils	I-cell_type
.	O

In	O
contrast	O
,	O
eosinophils	B-cell_type
purified	O
from	O
a	O
patient	O
with	O
Churg-Strauss	O
syndrome	O
and	O
from	O
six	O
patients	O
with	O
reactive	O
eosinophilias	O
attributed	O
to	O
allergy	O
,	O
parasitic	O
infection	O
,	O
or	O
drug	O
reaction	O
showed	O
a	O
polyclonal	O
pattern	O
of	O
X-inactivation	O
by	O
HUMARA	B-DNA
analysis	O
.	O

The	O
finding	O
of	O
clonal	O
eosinophilia	O
in	O
a	O
patient	O
presenting	O
with	O
IHES	O
indicates	O
that	O
such	O
patients	O
may	O
have	O
,	O
in	O
reality	O
,	O
a	O
low-grade	O
clonal	O
disorder	O
that	O
can	O
be	O
distinguished	O
from	O
reactive	O
eosinophilias	O
by	O
HUMARA	B-DNA
analysis	O
.	O

Further	O
,	O
the	O
method	O
described	O
can	O
be	O
used	O
to	O
monitor	O
disease	O
progression	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Clonality	NULL
of	NULL
Isolated	NULL
Eosinophils	NULL
in	NULL
the	NULL
Hypereosinophilic	NULL
Syndrome	NULL
By	NULL
Hsiao-Wen	NULL
Chang	NULL
,	NULL
Kah-Hoo	NULL
Leong	NULL
,	NULL
Dow	NULL
-Rhoon	NULL
Koh	NULL
,	NULL
and	NULL
Szu-Hee	NULL
Lee	NULL
The	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
(	NULL
IHES	NULL
)	NULL
is	NULL
a	NULL
rare	NULL
disorder	NULL
characterized	NULL
by	NULL
unexplained	NULL
,	NULL
persistent	NULL
eosinophilia	NULL
associated	NULL
with	NULL
multiple	NULL
organ	NULL
dysfunction	NULL
due	NULL
to	NULL
eosinophilic	NULL
tissue	NULL
infiltration	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
karyotypic	NULL
abnormalities	NULL
,	NULL
there	NULL
is	NULL
no	NULL
specific	NULL
test	NULL
to	NULL
detect	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
IHES	NULL
.	NULL

Analysis	NULL
of	NULL
X-chromosome	NULL
inactivation	NULL
patterns	NULL
can	NULL
be	NULL
used	NULL
to	NULL
determine	NULL
whether	NULL
proliferative	NULL
disorders	NULL
are	NULL
clonal	NULL
in	NULL
origin	NULL
.	NULL

Methylation	NULL
of	NULL
Hpall	NULL
and	NULL
Hha	NULL
|	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
trinucleotide	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
gene	NULL
(	NULL
HUMARA	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
X-inactivation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
used	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
with	NULL
nested	NULL
primers	NULL
to	NULL
analyze	NULL
X-inactivation	NULL
patterns	NULL
of	NULL
the	NULL
HUMARA	NULL
loci	NULL
in	NULL
purified	NULL
eosinophils	NULL
from	NULL
female	NULL
patients	NULL
with	NULL
eosinophilia	NULL
.	NULL

Peripheral	NULL
blood	NULL
eosinophils	NULL
were	NULL
isolated	NULL
by	NULL
their	NULL
autofluo-resence	NULL
using	NULL
flow	NULL
cytometric	NULL
sorting	NULL
.	NULL

Eosinophils	NULL
purified	NULL
from	NULL
a	NULL
female	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
were	NULL
found	NULL
to	NULL
HE	NULL
IDIOPATHIC	NULL
hypereosinophilic	NULL
syndrome	NULL
(	NULL
IHES	NULL
)	NULL
is	NULL
a	NULL
rare	NULL
disorder	NULL
characterized	NULL
by	NULL
persistent	NULL
eosinophilia	NULL
of	NULL
unknown	NULL
origin	NULL
often	NULL
associated	NULL
with	NULL
multiple	NULL
organ	NULL
dysfunction	NULL
as	NULL
a	NULL
result	NULL
of	NULL
infiltration	NULL
by	NULL
tissue	NULL
eosinophils	NULL
and	NULL
the	NULL
toxic	NULL
effects	NULL
of	NULL
their	NULL
released	NULL
granule	NULL
contents	NULL
.	NULL
``	NULL

There	NULL
is	NULL
no	NULL
specific	NULL
test	NULL
that	NULL
is	NULL
diagnostic	NULL
for	NULL
IHES	NULL
;	NULL
rather	NULL
the	NULL
syndrome	NULL
is	NULL
defined	NULL
as	NULL
the	NULL
combination	NULL
of	NULL
unexplained	NULL
prolonged	NULL
eosinophilia	NULL
and	NULL
evidence	NULL
of	NULL
organ	NULL
involvement	NULL
.	NULL

?	NULL

It	NULL
must	NULL
be	NULL
distinguished	NULL
from	NULL
reactive	NULL
,	NULL
clinically	NULL
benign	NULL
eosinophilia	NULL
associated	NULL
with	NULL
para-sitic	NULL
,	NULL
allergic	NULL
,	NULL
and	NULL
other	NULL
unexplained	NULL
causes	NULL
of	NULL
eosinophilia	NULL
,	NULL
``	NULL
and	NULL
also	NULL
from	NULL
eosinophilic	NULL
leukemias	NULL
associated	NULL
with	NULL
increased	NULL
blast	NULL
cells	NULL
and	NULL
cytogenetic	NULL
abnormalities	NULL
.	NULL

Moreover	NULL
,	NULL
some	NULL
patients	NULL
with	NULL
IHES	NULL
may	NULL
show	NULL
features	NULL
usually	NULL
associated	NULL
with	NULL
myeloproliferative	NULL
syndromes	NULL
such	NULL
as	NULL
splenomegaly	NULL
and	NULL
throm-bocytopenia	NULL
.	NULL

'*	NULL
``	NULL
Cases	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
as	NULL
evidenced	NULL
by	NULL
karyotypic	NULL
abnormalities	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
can	NULL
usually	NULL
be	NULL
classified	NULL
as	NULL
chronic	NULL
eosinophilic	NULL
leukemia	NULL
,	NULL
myelodysplastic	NULL
syndromes	NULL
,	NULL
or	NULL
myeloproliferative	NULL
disorders	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
karyotypic	NULL
abnormalities	NULL
,	NULL
the	NULL
distinction	NULL
between	NULL
these	NULL
entities	NULL
and	NULL
IHES	NULL
may	NULL
be	NULL
difficult	NULL
.	NULL

A	NULL
method	NULL
that	NULL
can	NULL
detect	NULL
clonal	NULL
eosinophilia	NULL
could	NULL
allow	NULL
more	NULL
accurate	NULL
diagnosis	NULL
and	NULL
treatment	NULL
of	NULL
cases	NULL
presenting	NULL
as	NULL
IHES	NULL
and	NULL
help	NULL
to	NULL
clarify	NULL
its	NULL
relationship	NULL
to	NULL
the	NULL
myeloproliferative	NULL
disorders	NULL
.	NULL

Analysis	NULL
of	NULL
maternal	NULL
and	NULL
paternal	NULL
X-chromosome	NULL
activation	NULL
status	NULL
has	NULL
been	NULL
used	NULL
as	NULL
a	NULL
means	NULL
of	NULL
determining	NULL
whether	NULL
certain	NULL
proliferative	NULL
disorders	NULL
are	NULL
clonal	NULL
in	NULL
origin	NULL
.	NULL

'~'*	NULL
These	NULL
methods	NULL
are	NULL
based	NULL
on	NULL
the	NULL
assumption	NULL
that	NULL
random	NULL
inactivation	NULL
of	NULL
one	NULL
X-chromosome	NULL
occurs	NULL
in	NULL
each	NULL
somatic	NULL
cell	NULL
during	NULL
early	NULL
embryo-genic	NULL
development	NULL
,	NULL
and	NULL
that	NULL
this	NULL
is	NULL
passed	NULL
on	NULL
to	NULL
the	NULL
progeny	NULL
of	NULL
the	NULL
cell	NULL
in	NULL
a	NULL
stable	NULL
fashion	NULL
.	NULL

'~'*	NULL
Therefore	NULL
,	NULL
some	NULL
cells	NULL
from	NULL
a	NULL
normal	NULL
female	NULL
carry	NULL
active	NULL
maternal	NULL
X-chromosome	NULL
,	NULL
while	NULL
other	NULL
cells	NULL
carry	NULL
active	NULL
paternal	NULL
X-chromosome	NULL
.	NULL

Differential	NULL
methylation	NULL
patterns	NULL
between	NULL
the	NULL
active	NULL
and	NULL
inactive	NULL
X-chromosome	NULL
have	NULL
been	NULL
documented	NULL
at	NULL
several	NULL
loci	NULL
such	NULL
as	NULL
the	NULL
phosphoglyc-erate	NULL
kinase	NULL
(	NULL
PGK	NULL
)	NULL
,	NULL
hypoxanthine	NULL
phosphoribosyl	NULL
transferase	NULL
(	NULL
HPRT	NULL
)	NULL
,	NULL
and	NULL
the	NULL
hypervariable	NULL
DXS255	NULL
(	NULL
M27B	NULL
)	NULL
loci	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
Allen	NULL
et	NULL
al°	NULL
have	NULL
shown	NULL
that	NULL
methylation	NULL
of	NULL
Hpall	NULL
and	NULL
Hha	NULL
|	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
trinucleotide	NULL
CAG	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
gene	NULL
(	NULL
HUMARA	NULL
)	NULL
correlates	NULL
with	NULL
X-inactivation	NULL
.	NULL

Digestion	NULL
of	NULL
DNA	NULL
with	NULL
a	NULL
methylation-sensitive	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
1651-1657	NULL
show	NULL
a	NULL
clonal	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
.	NULL

Eosinophil-depleted	NULL
leukocytes	NULL
from	NULL
this	NULL
patient	NULL
were	NULL
polyclonal	NULL
by	NULL
HUMARA	NULL
analysis	NULL
,	NULL
thus	NULL
excluding	NULL
skewedness	NULL
of	NULL
random	NULL
X-inactivation	NULL
.	NULL

After	NULL
corticosteroid	NULL
suppression	NULL
of	NULL
her	NULL
blood	NULL
eosinophilia	NULL
,	NULL
a	NULL
clonal	NULL
population	NULL
of	NULL
eosinophils	NULL
could	NULL
no	NULL
longer	NULL
be	NULL
detected	NULL
in	NULL
purified	NULL
eosinophils	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
eosinophils	NULL
purified	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
Churg-Strauss	NULL
syndrome	NULL
and	NULL
from	NULL
six	NULL
patients	NULL
with	NULL
reactive	NULL
eosinophilias	NULL
attributed	NULL
to	NULL
allergy	NULL
,	NULL
parasitic	NULL
infection	NULL
,	NULL
or	NULL
drug	NULL
reaction	NULL
showed	NULL
a	NULL
polyclonal	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
by	NULL
HUMARA	NULL
analysis	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
a	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
indicates	NULL
that	NULL
such	NULL
patients	NULL
may	NULL
have	NULL
,	NULL
in	NULL
reality	NULL
,	NULL
a	NULL
low-grade	NULL
clonal	NULL
disorder	NULL
that	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
reactive	NULL
eosinophilias	NULL
by	NULL
HUMARA	NULL
analysis	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
method	NULL
described	NULL
can	NULL
be	NULL
used	NULL
to	NULL
monitor	NULL
disease	NULL
progression	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

restriction	NULL
endonuclease	NULL
,	NULL
such	NULL
as	NULL
Hpall	NULL
,	NULL
permits	NULL
the	NULL
distinction	NULL
of	NULL
the	NULL
active	NULL
(	NULL
unmethylated	NULL
)	NULL
from	NULL
the	NULL
inactive	NULL
(	NULL
methylated	NULL
)	NULL
X-chromosome	NULL
.	NULL

Therefore	NULL
,	NULL
one	NULL
strategy	NULL
to	NULL
determine	NULL
whether	NULL
eosinophils	NULL
from	NULL
female	NULL
patients	NULL
with	NULL
IHES	NULL
are	NULL
clonal	NULL
would	NULL
be	NULL
to	NULL
analyze	NULL
the	NULL
X-inactivation	NULL
patterns	NULL
of	NULL
the	NULL
HUMARA	NULL
loci	NULL
in	NULL
purified	NULL
eosinophils	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
Luppi	NULL
et	NULL
al	NULL
'	NULL
``	NULL
analyzed	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
PGK	NULL
gene	NULL
in	NULL
granulocytes	NULL
from	NULL
a	NULL
female	NULL
IHES	NULL
patient	NULL
with	NULL
70	NULL
%	NULL
eosinophilia	NULL
and	NULL
found	NULL
this	NULL
to	NULL
show	NULL
a	NULL
clonal	NULL
pattern	NULL
by	NULL
Southern	NULL
hybridization	NULL
.	NULL

However	NULL
,	NULL
PGK	NULL
gene	NULL
analysis	NULL
is	NULL
restricted	NULL
by	NULL
a	NULL
low	NULL
incidence	NULL
of	NULL
constitutional	NULL
heterozygosity	NULL
of	NULL
approximately	NULL
40	NULL
%	NULL
in	NULL
the	NULL
general	NULL
female	NULL
population	NULL
.	NULL
``	NULL

''	NULL
By	NULL
contrast	NULL
,	NULL
the	NULL
HUMARA	NULL
loci	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
show	NULL
a	NULL
much	NULL
higher	NULL
incidence	NULL
of	NULL
constitutional	NULL
heterozygosity	NULL
of	NULL
approximately	NULL
90	NULL
%	NULL
.	NULL
``	NULL

Further	NULL
,	NULL
it	NULL
would	NULL
be	NULL
an	NULL
advantage	NULL
to	NULL
extend	NULL
such	NULL
studies	NULL
to	NULL
patients	NULL
with	NULL
lesser	NULL
proportions	NULL
of	NULL
eosinophils	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
by	NULL
isolating	NULL
eosinophils	NULL
for	NULL
clonality	NULL
analysis	NULL
.	NULL

Human	NULL
eosinophils	NULL
emit	NULL
marked	NULL
fluorescence	NULL
at	NULL
520	NULL
nm	NULL
when	NULL
excited	NULL
at	NULL
450	NULL
nm	NULL
due	NULL
to	NULL
their	NULL
fluorescent	NULL
granule	NULL
contents	NULL
,	NULL
and	NULL
this	NULL
property	NULL
may	NULL
be	NULL
used	NULL
to	NULL
purify	NULL
eosinophils	NULL
for	NULL
study	NULL
.	NULL
``	NULL

''	NULL
Here	NULL
,	NULL
we	NULL
have	NULL
purified	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
by	NULL
their	NULL
autofluorescence	NULL
using	NULL
flow	NULL
cytometric	NULL
sorting	NULL
and	NULL
investigated	NULL
the	NULL
clonality	NULL
of	NULL
purified	NULL
eosinophils	NULL
from	NULL
female	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
the	NULL
National	NULL
University	NULL
Medical	NULL
Institutes	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Physiology	NULL
,	NULL
National	NULL
University	NULL
of	NULL
Singapore	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Haematology	NULL
,	NULL
National	NULL
University	NULL
Hospital	NULL
,	NULL
Singapore	NULL
.	NULL

Submitted	NULL
March	NULL
25	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
October	NULL
21	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Medical	NULL
Research	NULL
Council	NULL
Grant	NULL
No	NULL
0040/94	NULL
.	NULL

H.-W.C.	NULL
was	NULL
a	NULL
Medical	NULL
Research	NULL
Scientist	NULL
Award	NULL
recipient	NULL
of	NULL
the	NULL
National	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
Singapore	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Szu-Hee	NULL
Lee	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Division	NULL
of	NULL
Haematology	NULL
,	NULL
National	NULL
University	NULL
Hospital	NULL
,	NULL
Singapore	NULL
119074	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9305-0001	NULL
$	NULL
3.00/0	NULL
1651	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1652	NULL
patients	NULL
by	NULL
analysis	NULL
of	NULL
X-inactivation	NULL
patterns	NULL
of	NULL
the	NULL
HUMARA	NULL
loci	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
amplification	NULL
with	NULL
nested	NULL
primers	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Sample	NULL
Preparation	NULL
Peripheral	NULL
blood	NULL
samples	NULL
in	NULL
EDTA	NULL
were	NULL
collected	NULL
from	NULL
the	NULL
patients	NULL
studied	NULL
.	NULL

Informed	NULL
consent	NULL
was	NULL
obtained	NULL
from	NULL
all	NULL
patients	NULL
in	NULL
this	NULL
study	NULL
,	NULL
which	NULL
was	NULL
approved	NULL
by	NULL
the	NULL
local	NULL
Institutional	NULL
Review	NULL
Board	NULL
(	NULL
Ethics	NULL
)	NULL
.	NULL

Red	NULL
blood	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
buffer	NULL
containing	NULL
15.5	NULL
mmol/L	NULL
NH	NULL
,	NULL
CI	NULL
,	NULL
1	NULL
mmol/L	NULL
KHCOs	NULL
;	NULL
,	NULL
and	NULL
10	NULL
umol/L	NULL
Na	NULL
;	NULL
EDTA	NULL
.	NULL

White	NULL
blood	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
2,000	NULL
rpm	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
resuspended	NULL
in	NULL
5	NULL
mL	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
washed	NULL
twice	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
then	NULL
separated	NULL
by	NULL
flow	NULL
cytometry	NULL
into	NULL
a	NULL
purified	NULL
eosinophil	NULL
fraction	NULL
and	NULL
an	NULL
eosinophil-depleted	NULL
leukocyte	NULL
fraction	NULL
.	NULL

Isolation	NULL
of	NULL
eosinophils	NULL
from	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
cell	NULL
sorting	NULL
.	NULL

Eosinophils	NULL
were	NULL
separated	NULL
by	NULL
flow	NULL
cytometry	NULL
based	NULL
on	NULL
their	NULL
autofluorescence	NULL
and	NULL
granularity	NULL
'*	NULL
'	NULL
to	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
purity	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
and	NULL
cell	NULL
sorting	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACStar	NULL
``	NULL
~	NULL
``	NULL
``	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Franklin	NULL
Lakes	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
excited	NULL
with	NULL
a	NULL
488-nm	NULL
argon	NULL
ion	NULL
laser	NULL
and	NULL
fluorescence	NULL
was	NULL
measured	NULL
through	NULL
a	NULL
BP	NULL
525	NULL
nm	NULL
(	NULL
FL1	NULL
detector	NULL
)	NULL
and	NULL
575	NULL
nm	NULL
(	NULL
FL2	NULL
)	NULL
filters	NULL
.	NULL

Results	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
LYSYS	NULL
II	NULL
version	NULL
1.1	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
sorted	NULL
at	NULL
a	NULL
cell	NULL
flow	NULL
rate	NULL
of	NULL
800	NULL
events/s	NULL
.	NULL

A	NULL
small	NULL
sample	NULL
of	NULL
sorted	NULL
cells	NULL
were	NULL
cytospun	NULL
onto	NULL
glass	NULL
slides	NULL
for	NULL
Giemsa	NULL
staining	NULL
to	NULL
confirm	NULL
either	NULL
eosinophil	NULL
purity	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
or	NULL
eosinophil	NULL
depletion	NULL
by	NULL
morphology	NULL
.	NULL

The	NULL
remainder	NULL
of	NULL
the	NULL
sorted	NULL
cells	NULL
were	NULL
processed	NULL
for	NULL
DNA	NULL
extraction	NULL
.	NULL

%	NULL
&	NULL
*	NULL
--	NULL
I	NULL
=	NULL
s	NULL
<	NULL
4	NULL
R7	NULL
.5	NULL
Eyal	NULL
e	NULL
t	NULL
©	NULL
I	NULL
3	NULL
=~	NULL
W	NULL
q-a	NULL
12	NULL
un	NULL
He	NULL
*C	NULL
4	NULL
,	NULL
>	NULL
dee	NULL
106	NULL
10	NULL
10	NULL
agr	NULL
10	NULL
FL1-Height	NULL
FL1-Height	NULL
®	NULL
mi	NULL
w	NULL
O	NULL
0	NULL
_	NULL
8	NULL
=	NULL
5	NULL
+..	NULL
C3	NULL
a	NULL
2	NULL
II	NULL
3	NULL
th	NULL
NB	NULL
|	NULL
ag	NULL
.	NULL
``	NULL

'	NULL
``	NULL
:	NULL
@	NULL
[	NULL
-_	NULL
83	NULL
___	NULL
,	NULL
o	NULL
|	NULL
eee	NULL
10°	NULL
105	NULL
10	NULL
%	NULL
10	NULL
``	NULL
40°	NULL
106	NULL
10	NULL
ar	NULL
ao	NULL
Ao	NULL
``	NULL
FL1.-Height	NULL
FL1-Height	NULL
CHANG	NULL
ET	NULL
AL	NULL
HUMARA	NULL
Analysis	NULL
Preparation	NULL
of	NULL
DNA	NULL
from	NULL
peripheral	NULL
blood	NULL
samples	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
.	NULL

``	NULL
>	NULL
2	NULL
``	NULL
Briefly	NULL
,	NULL
about	NULL
600	NULL
uL	NULL
of	NULL
solution	NULL
containing	NULL
50	NULL
mmol/L	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
mg/mL	NULL
proteinase	NULL
K	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
ug/ml	NULL
and	NULL
incubated	NULL
at	NULL
55°C	NULL
for	NULL
15	NULL
hours	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
extracted	NULL
once	NULL
with	NULL
phenol	NULL
,	NULL
twice	NULL
with	NULL
phenol-chloroform	NULL
,	NULL
and	NULL
precipitated	NULL
by	NULL
2.5	NULL
vol	NULL
of	NULL
ethanol	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
resuspended	NULL
in	NULL
200	NULL
uL	NULL
10	NULL
mmol/L	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
with	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
.	NULL

Clonality	NULL
studies	NULL
at	NULL
the	NULL
HUMARA	NULL
locus	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
,	NULL
``	NULL
except	NULL
that	NULL
internal	NULL
(	NULL
``	NULL
nested	NULL
``	NULL
)	NULL
primers	NULL
were	NULL
included	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
about	NULL
200	NULL
ng	NULL
of	NULL
DNA	NULL
was	NULL
either	NULL
digested	NULL
overnight	NULL
with	NULL
10	NULL
U	NULL
of	NULL
Hpall	NULL
or	NULL
not	NULL
digested	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
heating	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
uL	NULL
containing	NULL
0.5	NULL
umol/L	NULL
oligomers	NULL
,	NULL
150	NULL
umol/L	NULL
of	NULL
each	NULL
dNTP	NULL
(	NULL
Dupont	NULL
,	NULL
Wilmington	NULL
,	NULL
DE	NULL
)	NULL
,	NULL
2.5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
5	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
0.8	NULL
U	NULL
of	NULL
Taq	NULL
polymerase	NULL
,	NULL
and	NULL
200	NULL
ng	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
primers	NULL
were	NULL
:	NULL
5	NULL
``	NULL
TCCAGAATCTGTTCCAGAGCGTGC	NULL
3	NULL
'	NULL
(	NULL
primer	NULL
A	NULL
)	NULL
and	NULL
5	NULL
GCTGTGAAGGTTGCTGTTCCTCAT	NULL
3	NULL
'	NULL
(	NULL
primer	NULL
B	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
amplified	NULL
for	NULL
28	NULL
cycles	NULL
comprising	NULL
1	NULL
minute	NULL
at	NULL
95°C	NULL
,	NULL
45	NULL
seconds	NULL
at	NULL
60°C	NULL
,	NULL
and	NULL
45	NULL
seconds	NULL
at	NULL
72°C	NULL
with	NULL
initial	NULL
denaturation	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

One-tenth	NULL
volume	NULL
of	NULL
this	NULL
PCR	NULL
mixture	NULL
was	NULL
added	NULL
into	NULL
another	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
following	NULL
internal	NULL
primers	NULL
were	NULL
then	NULL
added	NULL
:	NULL
5	NULL
'	NULL
GTGCGCGAAGTGATCCAGGA	NULL
3	NULL
'	NULL
(	NULL
primer	NULL
A1	NULL
)	NULL
and	NULL
5	NULL
``	NULL
TTCCTCATC-CAGGACCAGGT	NULL
3	NULL
'	NULL
(	NULL
primer	NULL
B1	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
was	NULL
repeated	NULL
as	NULL
described	NULL
above	NULL
except	NULL
that	NULL
the	NULL
PCR	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
vol	NULL
of	NULL
10	NULL
uL	NULL
for	NULL
20	NULL
amplification	NULL
cycles	NULL
and	NULL
50	NULL
to	NULL
100	NULL
nmol/L	NULL
triphosphate	NULL
(	NULL
ATP	NULL
)	NULL
end-labeled	NULL
primer	NULL
A1	NULL
(	NULL
>	NULL
1,000	NULL
&	NULL
©	NULL
id	NULL
3	NULL
eal	NULL
4	NULL
3	NULL
£~	NULL
-	NULL
een	NULL
:	NULL
$	NULL
t	NULL
``	NULL
__	NULL
106	NULL
19	NULL
ar	NULL
ar	NULL
io	NULL
106	NULL
ao	NULL
ao	NULL
ao	NULL
50	NULL
``	NULL
FL1-Height	NULL
FL1	NULL
Height	NULL
8	NULL
3	NULL
=|	NULL
&	NULL
2	NULL
'|	NULL
F	NULL
Ai	NULL
Is	NULL
I	NULL
TO	NULL
j	NULL
.	NULL

fer	NULL
ades	NULL
.	NULL

w	NULL
I-L	NULL
:	NULL
-|	NULL
Jane	NULL
?	NULL
``	NULL

``	NULL
IF	NULL
AV	NULL
ir	NULL
iP	NULL
10	NULL
10	NULL
10	NULL
iP	NULL
10	NULL
aos	NULL
FL1-Height	NULL
FL1	NULL
Height	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Flow	NULL
cytometric	NULL
sorting	NULL
of	NULL
eosinophils	NULL
using	NULL
autofluorescence	NULL
and	NULL
light	NULL
scatter	NULL
patterns	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Peripheral	NULL
blood	NULL
leukocytes	NULL
from	NULL
case	NULL
1	NULL
were	NULL
obtained	NULL
from	NULL
whole	NULL
blood	NULL
after	NULL
removal	NULL
of	NULL
erythrocytes	NULL
by	NULL
lysis	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACStar	NULL
``	NULL
®	NULL
flow	NULL
cytometer	NULL
.	NULL

(	NULL
Al	NULL
)	NULL
The	NULL
populations	NULL
of	NULL
leukocytes	NULL
were	NULL
differentiated	NULL
by	NULL
their	NULL
side	NULL
scatter	NULL
and	NULL
autofluorescence	NULL
patterns	NULL
:	NULL
eosinophils	NULL
(	NULL
R1	NULL
,	NULL
57.9	NULL
%	NULL
)	NULL
,	NULL
granulocytes	NULL
(	NULL
R2	NULL
,	NULL
26.5	NULL
%	NULL
)	NULL
,	NULL
and	NULL
lymphocytes	NULL
(	NULL
R3	NULL
,	NULL
12.8	NULL
%	NULL
)	NULL
.	NULL

Cells	NULL
of	NULL
the	NULL
region	NULL
R1	NULL
exhibited	NULL
marked	NULL
autofluorescence	NULL
that	NULL
was	NULL
detected	NULL
on	NULL
FL1	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
on	NULL
FL2	NULL
.	NULL

Cells	NULL
in	NULL
R1	NULL
were	NULL
sorted	NULL
into	NULL
sterile	NULL
tubes	NULL
containing	NULL
2	NULL
mL	NULL
of	NULL
sterile	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

(	NULL
All	NULL
)	NULL
Resultant	NULL
cell	NULL
populations	NULL
contained	NULL
98.5	NULL
%	NULL
eosinophils	NULL
(	NULL
R1	NULL
)	NULL
,	NULL
1.0	NULL
%	NULL
granulocytes	NULL
(	NULL
R2	NULL
)	NULL
,	NULL
and	NULL
0.4	NULL
%	NULL
lymphocytes	NULL
(	NULL
R3	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Twenty-six	NULL
months	NULL
later	NULL
,	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
from	NULL
case	NULL
1	NULL
were	NULL
obtained	NULL
and	NULL
again	NULL
analyzed	NULL
on	NULL
a	NULL
FACStar	NULL
``	NULL
®	NULL
flow	NULL
cytometer	NULL
.	NULL

(	NULL
Bl	NULL
)	NULL
Eosinophil	NULL
(	NULL
R1	NULL
,	NULL
6.0	NULL
%	NULL
)	NULL
,	NULL
granulocyte	NULL
(	NULL
R2	NULL
,	NULL
74.0	NULL
%	NULL
)	NULL
,	NULL
and	NULL
lymphocyte	NULL
(	NULL
R3	NULL
,	NULL
17.3	NULL
%	NULL
)	NULL
populations	NULL
were	NULL
noted	NULL
among	NULL
the	NULL
leukocytes	NULL
.	NULL

Cells	NULL
in	NULL
R1	NULL
were	NULL
purified	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
.	NULL

(	NULL
Bll	NULL
)	NULL
The	NULL
resultant	NULL
cell	NULL
populations	NULL
contained	NULL
92.0	NULL
%	NULL
eosinophils	NULL
(	NULL
R1	NULL
)	NULL
,	NULL
4.0	NULL
%	NULL
granulocytes	NULL
(	NULL
R2	NULL
)	NULL
,	NULL
and	NULL
4.0	NULL
%	NULL
lymphocytes	NULL
(	NULL
R3	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EOSINOPHIL	NULL
CLONALITY	NULL
IN	NULL
IHES	NULL
Fig	NULL
2	NULL
.	NULL

Purified	NULL
eosinophils	NULL
isolated	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
.	NULL

Photomicrograph	NULL
showing	NULL
eosinophils	NULL
purified	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
to	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
pu-rity	NULL
.	NULL

(	NULL
Giemsa	NULL
,	NULL
x	NULL
1,300	NULL
original	NULL
magnification	NULL
)	NULL
.	NULL

h.	NULL
Ci/mmol	NULL
;	NULL
Dupont	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
sequencing	NULL
gel-loading	NULL
buffer	NULL
(	NULL
95	NULL
%	NULL
formamide	NULL
,	NULL
10	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.025	NULL
%	NULL
bromophe-nol	NULL
blue	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

Four	NULL
microliters	NULL
of	NULL
this	NULL
mixture	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
denaturing	NULL
6	NULL
%	NULL
(	NULL
39:1	NULL
acrylamide/bis	NULL
with	NULL
6	NULL
mol/L	NULL
urea	NULL
)	NULL
gel	NULL
and	NULL
electrophoresed	NULL
at	NULL
80	NULL
W	NULL
for	NULL
3	NULL
hours	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
.	NULL

HUMARA	NULL
clonality	NULL
analyses	NULL
of	NULL
all	NULL
the	NULL
samples	NULL
in	NULL
this	NULL
study	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
twice	NULL
to	NULL
ensure	NULL
that	NULL
the	NULL
results	NULL
were	NULL
reproducible	NULL
.	NULL

To	NULL
obtain	NULL
the	NULL
proportional	NULL
expression	NULL
of	NULL
the	NULL
maternal	NULL
and	NULL
paternal	NULL
alleles	NULL
in	NULL
HUMARA	NULL
analysis	NULL
,	NULL
band	NULL
intensities	NULL
from	NULL
the	NULL
autoradiographs	NULL
were	NULL
analyzed	NULL
using	NULL
Molecular	NULL
Analyst	NULL
software	NULL
(	NULL
Bio-Rad	NULL
Laborato-ries	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
proportional	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
alleles	NULL
was	NULL
obtained	NULL
as	NULL
described	NULL
by	NULL
Gale	NULL
et	NULL
al	NULL
,	NULL
``	NULL
``	NULL
except	NULL
that	NULL
the	NULL
final	NULL
ratio	NULL
was	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
total	NULL
signal	NULL
from	NULL
the	NULL
two	NULL
alleles	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
band	NULL
after	NULL
Hpall	NULL
digestion	NULL
was	NULL
first	NULL
corrected	NULL
by	NULL
dividing	NULL
it	NULL
by	NULL
the	NULL
signal	NULL
obtained	NULL
for	NULL
that	NULL
allele	NULL
in	NULL
the	NULL
undigested	NULL
sample	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
signals	NULL
from	NULL
the	NULL
two	NULL
alleles	NULL
was	NULL
then	NULL
expressed	NULL
as	NULL
a	NULL
ratio	NULL
.	NULL

The	NULL
ratio	NULL
was	NULL
finally	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
total	NULL
signal	NULL
for	NULL
the	NULL
two	NULL
alleles	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
ratio	NULL
of	NULL
50:50	NULL
would	NULL
represent	NULL
equal	NULL
(	NULL
balanced	NULL
)	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
alleles	NULL
.	NULL

RESULTS	NULL
Patients	NULL
Studies	NULL
were	NULL
performed	NULL
on	NULL
eight	NULL
female	NULL
patients	NULL
(	NULL
mean	NULL
age	NULL
,	NULL
48.5	NULL
years	NULL
;	NULL
range	NULL
,	NULL
41	NULL
to	NULL
65	NULL
years	NULL
)	NULL
with	NULL
eosinophilia	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
diagnosis	NULL
in	NULL
one	NULL
patient	NULL
(	NULL
case	NULL
1	NULL
)	NULL
was	NULL
consistent	NULL
with	NULL
IHES	NULL
,	NULL
and	NULL
in	NULL
another	NULL
(	NULL
case	NULL
2	NULL
)	NULL
,	NULL
with	NULL
the	NULL
Churg-Strauss	NULL
syndrome	NULL
.	NULL

Eosinophilia	NULL
in	NULL
the	NULL
remaining	NULL
patients	NULL
(	NULL
cases	NULL
3	NULL
to	NULL
8	NULL
)	NULL
was	NULL
judged	NULL
clinically	NULL
to	NULL
be	NULL
reactive	NULL
in	NULL
nature	NULL
based	NULL
on	NULL
a	NULL
likely	NULL
cause	NULL
for	NULL
eosinophilia	NULL
,	NULL
such	NULL
as	NULL
drug	NULL
reaction	NULL
due	NULL
to	NULL
phenytoin	NULL
(	NULL
case	NULL
3	NULL
)	NULL
,	NULL
parasitic	NULL
infection	NULL
due	NULL
to	NULL
Strongyloidiaisis	NULL
(	NULL
case	NULL
4	NULL
)	NULL
,	NULL
atopic	NULL
A	NULL
-	NULL
A1	NULL
Hpail	NULL
Hpall	NULL
-	NULL
>	NULL
-	NULL
>	NULL
|	NULL
|	NULL
(	NULL
CAG	NULL
)	NULL
n	NULL
t	NULL
&	NULL
B1	NULL
B	NULL
Fig	NULL
3	NULL
.	NULL

Diagram	NULL
of	NULL
the	NULL
region	NULL
amplified	NULL
in	NULL
the	NULL
HUMARA	NULL
gene	NULL
.	NULL

Two	NULL
Hpall	NULL
sites	NULL
are	NULL
adjacent	NULL
to	NULL
the	NULL
polymorphic	NULL
CAG	NULL
repeats	NULL
.	NULL

1653	NULL
eczema	NULL
secondary	NULL
to	NULL
house	NULL
dustmite	NULL
allergy	NULL
(	NULL
case	NULL
5	NULL
)	NULL
,	NULL
asthma	NULL
secondary	NULL
to	NULL
house	NULL
dustmite	NULL
allergy	NULL
(	NULL
case	NULL
6	NULL
)	NULL
,	NULL
and	NULL
extrinsic	NULL
allergic	NULL
asthma	NULL
(	NULL
cases	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
patients	NULL
with	NULL
reactive	NULL
eosinophilia	NULL
did	NULL
not	NULL
manifest	NULL
tissue	NULL
damage	NULL
attributable	NULL
to	NULL
eosinophilia	NULL
,	NULL
and	NULL
the	NULL
duration	NULL
of	NULL
eosinophilia	NULL
was	NULL
transient	NULL
in	NULL
cases	NULL
3	NULL
and	NULL
4	NULL
.	NULL

Details	NULL
of	NULL
the	NULL
patients	NULL
presenting	NULL
as	NULL
IHES	NULL
or	NULL
Churg-Strauss	NULL
syndrome	NULL
were	NULL
as	NULL
follows	NULL
.	NULL

Case	NULL
1	NULL
.	NULL

_	NULL
A	NULL
50-year-old	NULL
housewife	NULL
was	NULL
admitted	NULL
with	NULL
progressive	NULL
exertional	NULL
dyspnea	NULL
,	NULL
orthopnea	NULL
,	NULL
and	NULL
bilateral	NULL
ankle	NULL
swelling	NULL
for	NULL
several	NULL
days	NULL
.	NULL

She	NULL
gave	NULL
a	NULL
history	NULL
of	NULL
chronic	NULL
nonproductive	NULL
cough	NULL
for	NULL
several	NULL
months	NULL
and	NULL
weight	NULL
loss	NULL
of	NULL
10	NULL
kg	NULL
in	NULL
the	NULL
preceding	NULL
10	NULL
months	NULL
.	NULL

Examination	NULL
showed	NULL
physical	NULL
signs	NULL
of	NULL
severe	NULL
congestive	NULL
cardiac	NULL
failure	NULL
.	NULL

The	NULL
total	NULL
white	NULL
cell	NULL
count	NULL
was	NULL
13.5	NULL
X	NULL
10°/L	NULL
with	NULL
40	NULL
%	NULL
eosinophils	NULL
with	NULL
an	NULL
absolute	NULL
eosinophil	NULL
count	NULL
(	NULL
AEC	NULL
)	NULL
of	NULL
5.4	NULL
X	NULL
10°/L	NULL
and	NULL
a	NULL
mild	NULL
normochromic	NULL
anemia	NULL
(	NULL
hemoglobin	NULL
,	NULL
10.2	NULL
g/dL	NULL
)	NULL
with	NULL
occasional	NULL
macrocytes	NULL
in	NULL
the	NULL
blood	NULL
film	NULL
.	NULL

Liver	NULL
and	NULL
renal	NULL
biochemical	NULL
screening	NULL
tests	NULL
showed	NULL
mildly	NULL
elevated	NULL
serum	NULL
alanine	NULL
and	NULL
aspartate	NULL
aminotransferases	NULL
and	NULL
lactate	NULL
dehydrogenase	NULL
,	NULL
but	NULL
were	NULL
otherwise	NULL
normal	NULL
.	NULL

Chest	NULL
x-ray	NULL
showed	NULL
cardiac	NULL
enlargement	NULL
with	NULL
pulmonary	NULL
edema	NULL
.	NULL

Table	NULL
1	NULL
.	NULL

Clinical	NULL
Details	NULL
of	NULL
Patients	NULL
With	NULL
Eosinophilia	NULL
Case	NULL
Age	NULL
-	NULL
AEC*	NULL
Cause	NULL
of	NULL
Amplification	NULL
Pattern	NULL
No	NULL
.	NULL

(	NULL
yr	NULL
)	NULL
x	NULL
10	NULL
%	NULL
/L	NULL
Eosinophilia	NULL
at	NULL
HUMARA	NULL
Locus	NULL
1	NULL
50	NULL
5.4	NULL
-	NULL
IHESt	NULL
Clonal	NULL
2	NULL
43	NULL
-	NULL
11.6	NULL
-	NULL
Churg-Strauss	NULL
syndrome	NULL
Polyclonal	NULL
3	NULL
65	NULL
13.4	NULL
-	NULL
Reaction	NULL
to	NULL
phenytoin	NULL
Polyclonal	NULL
4	NULL
55	NULL
2.0	NULL
-	NULL
Strongyloidiasis	NULL
infection	NULL
Polyclonal	NULL
5	NULL
41	NULL
1.3	NULL
-	NULL
Atopic	NULL
eczema	NULL
,	NULL
house	NULL
dust-	NULL
Polyclonal	NULL
mite	NULL
allergy	NULL
6	NULL
40	NULL
1.2	NULL
-	NULL
Asthma	NULL
,	NULL
house	NULL
dustmite	NULL
Polyclonal	NULL
allergy	NULL
7	NULL
46	NULL
3.1	NULL
_-	NULL
Asthma	NULL
,	NULL
allergen	NULL
unknown	NULL
Polyclonal	NULL
8	NULL
48	NULL
3.0	NULL
_-	NULL
Asthma	NULL
,	NULL
allergen	NULL
unknown	NULL
Polyclonal	NULL
*	NULL
Absolute	NULL
eosinophil	NULL
count	NULL
at	NULL
initial	NULL
presentation	NULL
.	NULL

fldiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1654	NULL
Cardiac	NULL
doppler	NULL
echocardiography	NULL
confirmed	NULL
a	NULL
dilated	NULL
cardio-myopathy	NULL
with	NULL
poor	NULL
left	NULL
ventricular	NULL
function	NULL
and	NULL
a	NULL
small	NULL
pericardial	NULL
effusion	NULL
.	NULL

Serum	NULL
folate	NULL
was	NULL
low	NULL
at	NULL
6.6	NULL
nmol/L	NULL
(	NULL
normal	NULL
range	NULL
[	NULL
NR	NULL
]	NULL
=	NULL
10.0	NULL
to	NULL
40.0	NULL
nmol/L	NULL
)	NULL
.	NULL

Serum	NULL
vitamin	NULL
B	NULL
;	NULL
;	NULL
and	NULL
the	NULL
neutrophil	NULL
alkaline	NULL
phosphatase	NULL
score	NULL
were	NULL
in	NULL
the	NULL
normal	NULL
range	NULL
.	NULL

Polyclonal	NULL
IgE	NULL
was	NULL
increased	NULL
to	NULL
1,107	NULL
U/mL	NULL
(	NULL
NR	NULL
=	NULL
10.0	NULL
to	NULL
180	NULL
U/mL	NULL
)	NULL
.	NULL

Rheumatoid	NULL
factor	NULL
,	NULL
antinuclear	NULL
factor	NULL
,	NULL
and	NULL
anti-DNA	NULL
antibodies	NULL
were	NULL
negative	NULL
.	NULL

Stool	NULL
examinations	NULL
for	NULL
ova	NULL
,	NULL
cysts	NULL
,	NULL
and	NULL
parasites	NULL
were	NULL
repeatedly	NULL
negative	NULL
.	NULL

The	NULL
bone	NULL
marrow	NULL
aspirate	NULL
showed	NULL
moderately	NULL
hypercellular	NULL
fragments	NULL
with	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
eosinophils	NULL
and	NULL
eosinophilic	NULL
precursors	NULL
.	NULL

Cytogenetic	NULL
analysis	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
showed	NULL
a	NULL
normal	NULL
karyotype	NULL
.	NULL

She	NULL
was	NULL
treated	NULL
with	NULL
diuretics	NULL
and	NULL
folic	NULL
acid	NULL
and	NULL
started	NULL
on	NULL
prednisolone	NULL
1	NULL
mg/kg/d	NULL
.	NULL

Her	NULL
symptoms	NULL
improved	NULL
dramatically	NULL
with	NULL
a	NULL
fall	NULL
in	NULL
the	NULL
AEC	NULL
to	NULL
0.4	NULL
X	NULL
10°/L	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
.	NULL

During	NULL
the	NULL
first	NULL
12	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
,	NULL
her	NULL
AEC	NULL
rose	NULL
above	NULL
1.5	NULL
X	NULL
10°/L	NULL
on	NULL
several	NULL
occasions	NULL
,	NULL
accompanied	NULL
by	NULL
symptoms	NULL
and	NULL
signs	NULL
of	NULL
congestive	NULL
heart	NULL
failure	NULL
.	NULL

As	NULL
she	NULL
refused	NULL
therapy	NULL
,	NULL
control	NULL
was	NULL
reestablished	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
prednisolone	NULL
dosage	NULL
.	NULL

Twelve	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
,	NULL
due	NULL
to	NULL
increasing	NULL
side	NULL
effects	NULL
of	NULL
corticosteroid	NULL
therapy	NULL
,	NULL
hydroxyurea	NULL
was	NULL
substituted	NULL
for	NULL
prednisolone	NULL
,	NULL
but	NULL
had	NULL
to	NULL
be	NULL
discontinued	NULL
20	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
due	NULL
to	NULL
worsening	NULL
macrocytic	NULL
anemia	NULL
.	NULL

From	NULL
that	NULL
time	NULL
until	NULL
the	NULL
present	NULL
,	NULL
the	NULL
patient	NULL
has	NULL
been	NULL
maintained	NULL
on	NULL
a	NULL
small	NULL
dose	NULL
of	NULL
prednisolone	NULL
to	NULL
suppress	NULL
her	NULL
eosinophil	NULL
count	NULL
.	NULL

During	NULL
treatment	NULL
,	NULL
her	NULL
serum	NULL
IgE	NULL
level	NULL
fell	NULL
,	NULL
but	NULL
remained	NULL
mildly	NULL
elevated	NULL
at	NULL
356	NULL
U/mL	NULL
,	NULL
26	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
.	NULL

HUMARA	NULL
analysis	NULL
of	NULL
purified	NULL
blood	NULL
eosinophils	NULL
was	NULL
performed	NULL
at	NULL
initial	NULL
presentation	NULL
and	NULL
at	NULL
26	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
.	NULL

Case	NULL
2	NULL
.	NULL

A	NULL
43-year-old	NULL
Caucasian	NULL
woman	NULL
presented	NULL
with	NULL
rashes	NULL
on	NULL
her	NULL
hands	NULL
and	NULL
paraesthesia	NULL
and	NULL
swelling	NULL
of	NULL
her	NULL
feet	NULL
for	NULL
10	NULL
days	NULL
.	NULL

She	NULL
gave	NULL
a	NULL
history	NULL
of	NULL
asthma	NULL
for	NULL
about	NULL
15	NULL
years	NULL
,	NULL
controlled	NULL
with	NULL
intermittent	NULL
courses	NULL
of	NULL
corticosteroids	NULL
and	NULL
salbutamol	NULL
.	NULL

Fifteen	NULL
years	NULL
ago	NULL
,	NULL
in	NULL
a	NULL
hospital	NULL
abroad	NULL
,	NULL
she	NULL
had	NULL
been	NULL
diagnosed	NULL
with	NULL
``	NULL
pulmonary	NULL
eosinophilia	NULL
``	NULL
and	NULL
2	NULL
years	NULL
previ-ously	NULL
,	NULL
she	NULL
had	NULL
suffered	NULL
a	NULL
severe	NULL
angioneurotic	NULL
orbital	NULL
cellulitis	NULL
.	NULL

On	NULL
examination	NULL
she	NULL
had	NULL
vasculitic	NULL
lesions	NULL
on	NULL
her	NULL
hands	NULL
and	NULL
sensory	NULL
loss	NULL
to	NULL
pinprick	NULL
in	NULL
a	NULL
``	NULL
glove	NULL
and	NULL
stocking	NULL
``	NULL
distribution	NULL
of	NULL
her	NULL
hands	NULL
and	NULL
feet	NULL
and	NULL
bilateral	NULL
pitting	NULL
edema	NULL
up	NULL
to	NULL
the	NULL
midcalves	NULL
.	NULL

Chest	NULL
radiography	NULL
showed	NULL
old	NULL
scarring	NULL
and	NULL
small	NULL
areas	NULL
of	NULL
``	NULL
ground	NULL
glass	NULL
``	NULL
appearance	NULL
consistent	NULL
with	NULL
pulmonary	NULL
allergic	NULL
granulomatosis	NULL
.	NULL

The	NULL
total	NULL
white	NULL
cell	NULL
count	NULL
was	NULL
26.5	NULL
%	NULL
10°/L	NULL
,	NULL
with	NULL
43	NULL
%	NULL
eosinophils	NULL
.	NULL

Biopsy	NULL
of	NULL
the	NULL
skin	NULL
lesions	NULL
showed	NULL
vasculitis	NULL
and	NULL
tissue	NULL
eosinophilia	NULL
.	NULL

IgE	NULL
levels	NULL
were	NULL
elevated	NULL
(	NULL
895	NULL
U/mL	NULL
)	NULL
.	NULL

Nerve	NULL
conduction	NULL
studies	NULL
showed	NULL
a	NULL
mild	NULL
sensory	NULL
neuropathy	NULL
of	NULL
the	NULL
lower	NULL
limbs	NULL
.	NULL

A	NULL
large	NULL
pericardial	NULL
effusion	NULL
was	NULL
confirmed	NULL
by	NULL
doppler	NULL
echocardiography	NULL
.	NULL

Antineutrophil	NULL
cytoplas-mic	NULL
antibodies	NULL
,	NULL
anti-DNA	NULL
antibodies	NULL
,	NULL
rheumatoid	NULL
factor	NULL
,	NULL
and	NULL
antifilarial	NULL
antibody	NULL
were	NULL
negative	NULL
.	NULL

A	NULL
diagnosis	NULL
of	NULL
Churg-Strauss	NULL
syndrome	NULL
with	NULL
peripheral	NULL
neuropathy	NULL
and	NULL
myositis	NULL
was	NULL
made	NULL
.	NULL

Her	NULL
symptoms	NULL
are	NULL
presently	NULL
well-controlled	NULL
with	NULL
prednisolone	NULL
and	NULL
salbutamol	NULL
.	NULL

HUMARA	NULL
Analysis	NULL
Amplification	NULL
of	NULL
the	NULL
HUMARA	NULL
gene	NULL
by	NULL
nested	NULL
primers	NULL
gives	NULL
a	NULL
240-bp	NULL
fragment	NULL
that	NULL
spans	NULL
two	NULL
Hpall	NULL
cutting	NULL
sites	NULL
and	NULL
the	NULL
variable	NULL
CAG	NULL
tandem	NULL
repeats	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
HUMARA	NULL
CHANG	NULL
ET	NULL
AL	NULL
gene	NULL
is	NULL
based	NULL
on	NULL
the	NULL
rationale	NULL
that	NULL
amplification	NULL
by	NULL
PCR	NULL
can	NULL
not	NULL
take	NULL
place	NULL
if	NULL
the	NULL
active	NULL
(	NULL
unmethylated	NULL
)	NULL
X-chromosome	NULL
is	NULL
predigested	NULL
with	NULL
a	NULL
methylation	NULL
sensitive	NULL
enzyme	NULL
(	NULL
Hpall	NULL
)	NULL
.	NULL

Methylation	NULL
at	NULL
these	NULL
sites	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
X-inactivation	NULL
,	NULL
``	NULL
so	NULL
that	NULL
a	NULL
product	NULL
will	NULL
only	NULL
be	NULL
obtained	NULL
if	NULL
the	NULL
X-chromosome	NULL
is	NULL
inactive	NULL
.	NULL

In	NULL
a	NULL
polyclonal	NULL
cell	NULL
population	NULL
in	NULL
which	NULL
random	NULL
X-inactivation	NULL
has	NULL
taken	NULL
place	NULL
,	NULL
both	NULL
alleles	NULL
persist	NULL
after	NULL
Hpall	NULL
predigestion	NULL
so	NULL
that	NULL
in	NULL
a	NULL
high	NULL
resolution	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
two	NULL
bands	NULL
are	NULL
seen	NULL
,	NULL
as	NULL
the	NULL
maternal	NULL
inactive	NULL
X-allele	NULL
is	NULL
distinct	NULL
from	NULL
paternal	NULL
inactive	NULL
X-allele	NULL
because	NULL
of	NULL
a	NULL
different	NULL
number	NULL
of	NULL
CAG	NULL
repeats	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
in	NULL
a	NULL
monoclonal	NULL
cell	NULL
population	NULL
in	NULL
which	NULL
nonrandom	NULL
X-inactivation	NULL
has	NULL
taken	NULL
place	NULL
,	NULL
the	NULL
active	NULL
allele	NULL
disappears	NULL
after	NULL
Hpall	NULL
predigestion	NULL
,	NULL
as	NULL
all	NULL
cells	NULL
contain	NULL
the	NULL
same	NULL
inactive	NULL
X-chromosome	NULL
,	NULL
``	NULL
so	NULL
that	NULL
only	NULL
one	NULL
band	NULL
from	NULL
either	NULL
parental	NULL
inactive	NULL
X-allele	NULL
is	NULL
shown	NULL
by	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
band	NULL
representing	NULL
an	NULL
allele	NULL
is	NULL
sometimes	NULL
accompanied	NULL
by	NULL
a	NULL
minor	NULL
band	NULL
one	NULL
trinucleotide	NULL
repeat	NULL
smaller	NULL
,	NULL
which	NULL
is	NULL
due	NULL
to	NULL
slippage	NULL
of	NULL
Taq	NULL
polymerase	NULL
along	NULL
the	NULL
repeated	NULL
sequences	NULL
.	NULL
``	NULL

''	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
hypervariable	NULL
HUMARA	NULL
target	NULL
gene	NULL
was	NULL
performed	NULL
on	NULL
both	NULL
purified	NULL
eosinophil	NULL
fractions	NULL
and	NULL
eosinophil-depleted	NULL
leukocyte	NULL
fractions	NULL
from	NULL
each	NULL
patient	NULL
.	NULL

Eosinophil-depleted	NULL
leukocyte	NULL
fractions	NULL
consisted	NULL
of	NULL
variable	NULL
proportions	NULL
of	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
peripheral	NULL
blood	NULL
neutro-phils	NULL
,	NULL
lymphocytes	NULL
,	NULL
and	NULL
monocytes	NULL
,	NULL
with	NULL
fewer	NULL
than	NULL
10	NULL
%	NULL
eosinophils	NULL
.	NULL

These	NULL
fractions	NULL
served	NULL
as	NULL
polyclonal	NULL
controls	NULL
to	NULL
exclude	NULL
skewedness	NULL
of	NULL
X-inactivation	NULL
that	NULL
is	NULL
found	NULL
in	NULL
a	NULL
small	NULL
proportion	NULL
of	NULL
females	NULL
in	NULL
HUMARA	NULL
analysis	NULL
.	NULL

>	NULL
``	NULL
``	NULL
In	NULL
the	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
(	NULL
case	NULL
1	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
were	NULL
purified	NULL
to	NULL
98.5	NULL
%	NULL
purity	NULL
by	NULL
flow	NULL
cytometry	NULL
at	NULL
initial	NULL
presentation	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Gel	NULL
electrophoresis	NULL
under	NULL
denaturing	NULL
conditions	NULL
of	NULL
Hpall-digested	NULL
samples	NULL
of	NULL
eosinophil-depleted	NULL
leukocytes	NULL
showed	NULL
a	NULL
band	NULL
originating	NULL
from	NULL
each	NULL
parental	NULL
X-chromosome	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
cases	NULL
1A	NULL
and	NULL
1B	NULL
,	NULL
WBC-	NULL
)	NULL
.	NULL

Eosinophil-depleted	NULL
leukocyte	NULL
fractions	NULL
from	NULL
case	NULL
1	NULL
,	NULL
therefore	NULL
,	NULL
showed	NULL
a	NULL
random	NULL
(	NULL
polyclonal	NULL
)	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
,	NULL
thus	NULL
excluding	NULL
extreme	NULL
skewedness	NULL
of	NULL
X-inactivation	NULL
in	NULL
this	NULL
individual	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
HUMARA	NULL
analysis	NULL
of	NULL
the	NULL
purified	NULL
eosinophil	NULL
fraction	NULL
from	NULL
this	NULL
patient	NULL
at	NULL
initial	NULL
presentation	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
case	NULL
1A	NULL
,	NULL
EO	NULL
)	NULL
showed	NULL
only	NULL
a	NULL
band	NULL
from	NULL
one	NULL
parental	NULL
allele	NULL
after	NULL
Hpall	NULL
digestion	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
nonrandom	NULL
(	NULL
clonal	NULL
)	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
in	NULL
the	NULL
purified	NULL
eosinophils	NULL
.	NULL

Twenty-six	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
when	NULL
the	NULL
patient	NULL
's	NULL
symptoms	NULL
and	NULL
blood	NULL
eosinophil	NULL
count	NULL
(	NULL
AEC	NULL
=	NULL
0.5	NULL
x	NULL
10°/L	NULL
)	NULL
were	NULL
controlled	NULL
with	NULL
a	NULL
small	NULL
dose	NULL
of	NULL
prednisolone	NULL
,	NULL
eosinophils	NULL
were	NULL
once	NULL
again	NULL
purified	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
for	NULL
HUMARA	NULL
reanalysis	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
case	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
eosinophil	NULL
content	NULL
of	NULL
the	NULL
purified	NULL
eosinophil	NULL
fraction	NULL
was	NULL
92	NULL
%	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

By	NULL
HUMARA	NULL
analysis	NULL
,	NULL
a	NULL
polyclonal	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
was	NULL
seen	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
case	NULL
1B	NULL
,	NULL
EO	NULL
)	NULL
,	NULL
indicating	NULL
either	NULL
that	NULL
the	NULL
clonal	NULL
eosinophilic	NULL
population	NULL
was	NULL
absent	NULL
or	NULL
that	NULL
it	NULL
was	NULL
insufficient	NULL
,	NULL
as	NULL
a	NULL
proportion	NULL
of	NULL
the	NULL
total	NULL
eosinophil	NULL
population	NULL
,	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
a	NULL
clonal	NULL
pattern	NULL
.	NULL

Samples	NULL
from	NULL
case	NULL
1	NULL
were	NULL
also	NULL
assayed	NULL
for	NULL
clonality	NULL
using	NULL
PGK	NULL
gene	NULL
analysis	NULL
by	NULL
PCR	NULL
,	NULL
*	NULL
``	NULL
but	NULL
the	NULL
patient	NULL
was	NULL
not	NULL
heterozygous	NULL
at	NULL
the	NULL
PGK	NULL
locus	NULL
,	NULL
which	NULL
was	NULL
therefore	NULL
uninformative	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
case	NULL
2	NULL
,	NULL
a	NULL
patient	NULL
with	NULL
the	NULL
Churg-Strauss	NULL
syndrome	NULL
,	NULL
HUMARA	NULL
analysis	NULL
of	NULL
both	NULL
purified	NULL
eosinophil	NULL
and	NULL
eosinophil	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EOSINOPHIL	NULL
CLONALITY	NULL
IN	NULL
IHES	NULL
Case	NULL
1A	NULL
Sample	NULL
EO	NULL
WBC-Hpall	NULL
:	NULL
400-0	NULL
#	NULL
%	NULL
allelic	NULL
ratio*	NULL
:	NULL
19:81	NULL
45:55	NULL
eosinophiliat	NULL
:	NULL
40	NULL
%	NULL
Case	NULL
3	NULL
Sample	NULL
EO	NULL
WBC-Hpall	NULL
:	NULL
+0	NULL
-	NULL
+	NULL
51:49	NULL
55:45	NULL
12	NULL
%	NULL
%	NULL
allelic	NULL
ratio*	NULL
:	NULL
eosinophiliat	NULL
:	NULL
1655	NULL
400	NULL
-	NULL
o	NULL
$	NULL
_-	NULL
#	NULL
00	NULL
ke	NULL
#	NULL
~	NULL
bave	NULL
Apmen	NULL
v	NULL
``	NULL
rak	NULL
~	NULL
met	NULL
r	NULL
o	NULL
‘	NULL
Mﬁ	NULL
’	NULL
ﬁ	NULL
56:44	NULL
51:49	NULL
45:55	NULL
40:60	NULL
5	NULL
%	NULL
43	NULL
%	NULL
53:47	NULL
52:48	NULL
30	NULL
%	NULL
51:49	NULL
48:52	NULL
20	NULL
%	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
HUMARA	NULL
analysis	NULL
of	NULL
patients	NULL
with	NULL
eosinophilia	NULL
.	NULL

Case	NULL
1	NULL
,	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
;	NULL
case	NULL
2	NULL
,	NULL
Churg-Strauss	NULL
syndrome	NULL
;	NULL
case	NULL
3	NULL
,	NULL
eosinophilia	NULL
secondary	NULL
to	NULL
phenytoin	NULL
ingestion	NULL
;	NULL
case	NULL
4	NULL
,	NULL
eosinophilia	NULL
secondary	NULL
to	NULL
Strongyloidiasis	NULL
infection	NULL
;	NULL
and	NULL
case	NULL
5	NULL
,	NULL
eosinophilia	NULL
secondary	NULL
to	NULL
house	NULL
dustmite	NULL
allergy	NULL
causing	NULL
atopic	NULL
eczema	NULL
.	NULL

Case	NULL
1A	NULL
,	NULL
sample	NULL
obtained	NULL
at	NULL
initial	NULL
presentation	NULL
;	NULL
case	NULL
1B	NULL
,	NULL
sample	NULL
obtained	NULL
26	NULL
months	NULL
after	NULL
initial	NULL
presentation	NULL
;	NULL
EO	NULL
,	NULL
purified	NULL
eosinophil	NULL
fraction	NULL
;	NULL
WBC-	NULL
,	NULL
eosinophil-depleted	NULL
leukocyte	NULL
fraction	NULL
;	NULL
+	NULL
,	NULL
DNA	NULL
amplified	NULL
after	NULL
Hpall	NULL
precutting	NULL
;	NULL
-	NULL
,	NULL
DNA	NULL
amplified	NULL
without	NULL
Hpall	NULL
precutting	NULL
;	NULL
*	NULL
,	NULL
percent	NULL
allelic	NULL
ratio	NULL
:	NULL
this	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
band	NULL
intensity	NULL
of	NULL
the	NULL
upper	NULL
allele	NULL
to	NULL
the	NULL
lower	NULL
allele	NULL
after	NULL
Hpall	NULL
digestion	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
total	NULL
intensity	NULL
of	NULL
the	NULL
two	NULL
alleles	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
each	NULL
band	NULL
after	NULL
Hpall	NULL
digestion	NULL
was	NULL
first	NULL
corrected	NULL
by	NULL
dividing	NULL
it	NULL
by	NULL
the	NULL
signal	NULL
obtained	NULL
for	NULL
that	NULL
allele	NULL
in	NULL
the	NULL
undigested	NULL
sample	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

{	NULL
,	NULL
eosinophilia	NULL
:	NULL
percentage	NULL
eosinophils	NULL
of	NULL
the	NULL
peripheral	NULL
blood	NULL
total	NULL
w	NULL
hite	NULL
cell	NULL
count	NULL
before	NULL
eosinophil	NULL
purification	NULL
.	NULL

depleted	NULL
leukocyte	NULL
fractions	NULL
showed	NULL
a	NULL
similar	NULL
polyclonal	NULL
pattern	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
case	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
purified	NULL
eosinophils	NULL
were	NULL
of	NULL
polyclonal	NULL
origin	NULL
in	NULL
this	NULL
condition	NULL
.	NULL

In	NULL
all	NULL
of	NULL
the	NULL
other	NULL
six	NULL
patients	NULL
with	NULL
reactive	NULL
eosinophilia	NULL
,	NULL
HUMARA	NULL
analyses	NULL
of	NULL
both	NULL
purified	NULL
eosinophil	NULL
and	NULL
eosinophil-depleted	NULL
leukocyte	NULL
fractions	NULL
showed	NULL
a	NULL
polyclonal	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
eosinophil	NULL
populations	NULL
in	NULL
these	NULL
patients	NULL
were	NULL
polyclonal	NULL
in	NULL
origin	NULL
.	NULL

Representative	NULL
analyses	NULL
are	NULL
shown	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
cases	NULL
3	NULL
to	NULL
5	NULL
)	NULL
.	NULL

HUMARA	NULL
results	NULL
in	NULL
all	NULL
samples	NULL
in	NULL
this	NULL
study	NULL
were	NULL
found	NULL
to	NULL
be	NULL
consistent	NULL
on	NULL
repeated	NULL
analyses	NULL
.	NULL

DISCUSSION	NULL
The	NULL
distinction	NULL
between	NULL
a	NULL
malignant	NULL
and	NULL
nonmalignant	NULL
process	NULL
in	NULL
IHES	NULL
can	NULL
be	NULL
extremely	NULL
difficult	NULL
,	NULL
as	NULL
there	NULL
are	NULL
no	NULL
specific	NULL
markers	NULL
that	NULL
can	NULL
be	NULL
applied	NULL
to	NULL
ascertain	NULL
the	NULL
clonality	NULL
of	NULL
eosinophils	NULL
.	NULL
``	NULL

We	NULL
have	NULL
attempted	NULL
to	NULL
solve	NULL
this	NULL
problem	NULL
by	NULL
analysis	NULL
of	NULL
the	NULL
X-inactivation	NULL
status	NULL
of	NULL
the	NULL
HUMARA	NULL
loci	NULL
in	NULL
purified	NULL
eosinophils	NULL
from	NULL
female	NULL
patients	NULL
with	NULL
eosinophilia	NULL
.	NULL

One	NULL
patient	NULL
presented	NULL
with	NULL
IHES	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
recurrent	NULL
elevated	NULL
AEC	NULL
and	NULL
organ	NULL
damage	NULL
involving	NULL
the	NULL
heart	NULL
.	NULL

A	NULL
second	NULL
patient	NULL
presented	NULL
with	NULL
vasculitic	NULL
lesions	NULL
,	NULL
asthma	NULL
,	NULL
pulmonary	NULL
eosinophilia	NULL
,	NULL
peripheral	NULL
neuropathy	NULL
,	NULL
pericarditis	NULL
,	NULL
and	NULL
myositis	NULL
and	NULL
clinically	NULL
fulfilled	NULL
the	NULL
criteria	NULL
for	NULL
the	NULL
Churg-Strauss	NULL
syn-drome	NULL
.	NULL

``	NULL
>	NULL
``	NULL
The	NULL
remaining	NULL
six	NULL
patients	NULL
with	NULL
reactive	NULL
eosinophilia	NULL
showed	NULL
either	NULL
transient	NULL
or	NULL
persistent	NULL
eosinophilia	NULL
that	NULL
was	NULL
attributable	NULL
to	NULL
drug	NULL
reactions	NULL
,	NULL
allergies	NULL
,	NULL
or	NULL
parasitic	NULL
infection	NULL
.	NULL

These	NULL
cases	NULL
were	NULL
clinically	NULL
benign	NULL
and	NULL
did	NULL
not	NULL
show	NULL
evidence	NULL
of	NULL
organ	NULL
damage	NULL
associated	NULL
with	NULL
eosinophilia	NULL
.	NULL

By	NULL
X-inactivation	NULL
analysis	NULL
,	NULL
we	NULL
found	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
the	NULL
patient	NULL
with	NULL
IHES	NULL
,	NULL
whereas	NULL
eosinophils	NULL
were	NULL
polyclonal	NULL
in	NULL
the	NULL
patient	NULL
with	NULL
Churg-Strauss	NULL
syndrome	NULL
,	NULL
and	NULL
also	NULL
in	NULL
the	NULL
six	NULL
other	NULL
patients	NULL
with	NULL
reactive	NULL
eosinophilia	NULL
.	NULL

Further	NULL
,	NULL
in	NULL
the	NULL
patient	NULL
with	NULL
IHES	NULL
,	NULL
analysis	NULL
of	NULL
eosinophil-depleted	NULL
leukocyte	NULL
fractions	NULL
showed	NULL
a	NULL
polyclonal	NULL
pattern	NULL
of	NULL
X-inactivation	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
the	NULL
clonal	NULL
pattern	NULL
observed	NULL
in	NULL
purified	NULL
eosinophils	NULL
at	NULL
initial	NULL
presentation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
skewedness	NULL
of	NULL
random	NULL
X-inactivation	NULL
that	NULL
could	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
result	NULL
in	NULL
an	NULL
imbalanced	NULL
expression	NULL
of	NULL
one	NULL
allele	NULL
in	NULL
a	NULL
population	NULL
of	NULL
cells	NULL
.	NULL

Our	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
showed	NULL
similarities	NULL
to	NULL
the	NULL
case	NULL
described	NULL
by	NULL
Luppi	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
Both	NULL
patients	NULL
showed	NULL
evidence	NULL
of	NULL
organ	NULL
damage	NULL
associated	NULL
with	NULL
sustained	NULL
eosinophilia	NULL
,	NULL
an	NULL
absence	NULL
of	NULL
features	NULL
associated	NULL
with	NULL
myeloproliferative	NULL
disor-ders	NULL
,	NULL
a	NULL
normal	NULL
bone	NULL
marrow	NULL
karyotype	NULL
,	NULL
a	NULL
clonal	NULL
eosinophilia	NULL
by	NULL
X-inactivation	NULL
analysis	NULL
,	NULL
and	NULL
corticosteroid-responsiveness	NULL
with	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1656	NULL
a	NULL
favorable	NULL
outcome	NULL
.	NULL

In	NULL
our	NULL
patient	NULL
(	NULL
case	NULL
1	NULL
)	NULL
,	NULL
a	NULL
very	NULL
high	NULL
IgE	NULL
level	NULL
at	NULL
presentation	NULL
was	NULL
also	NULL
found	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
good	NULL
prognosis	NULL
in	NULL
IHES	NULL
.	NULL
``	NULL

After	NULL
therapy	NULL
,	NULL
the	NULL
IgE	NULL
level	NULL
fell	NULL
,	NULL
but	NULL
remained	NULL
mildly	NULL
elevated	NULL
,	NULL
although	NULL
clonal	NULL
eosinophilia	NULL
could	NULL
no	NULL
longer	NULL
be	NULL
demonstrated	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
38	NULL
%	NULL
of	NULL
IHES	NULL
patients	NULL
were	NULL
found	NULL
to	NULL
have	NULL
markedly	NULL
elevated	NULL
IgE	NULL
levels	NULL
,	NULL
suggesting	NULL
an	NULL
association	NULL
between	NULL
an	NULL
IgE-mediated	NULL
mechanism	NULL
and	NULL
eosinophilia	NULL
in	NULL
this	NULL
subgroup	NULL
.	NULL

?	NULL
``	NULL

These	NULL
patients	NULL
required	NULL
no	NULL
therapy	NULL
or	NULL
responded	NULL
with	NULL
a	NULL
complete	NULL
remission	NULL
when	NULL
treated	NULL
with	NULL
corticosteroids	NULL
.	NULL
``	NULL

This	NULL
interesting	NULL
association	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
eosinophilia	NULL
and	NULL
perhaps	NULL
the	NULL
organ	NULL
damage	NULL
in	NULL
this	NULL
subgroup	NULL
of	NULL
patients	NULL
with	NULL
IHES	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
IgE-mediated	NULL
hypersensitivity	NULL
response	NULL
to	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
antigen	NULL
or	NULL
antigens	NULL
.	NULL
``	NULL

One	NULL
advantage	NULL
of	NULL
HUMARA	NULL
analysis	NULL
compared	NULL
with	NULL
other	NULL
X-inactivation	NULL
markers	NULL
is	NULL
its	NULL
high	NULL
degree	NULL
of	NULL
informativeness	NULL
,	NULL
as	NULL
the	NULL
HUMARA	NULL
loci	NULL
show	NULL
a	NULL
high	NULL
incidence	NULL
of	NULL
constitutional	NULL
heterozygosity	NULL
of	NULL
approximately	NULL
90	NULL
%	NULL
in	NULL
the	NULL
female	NULL
population	NULL
.	NULL
``	NULL

''	NULL
By	NULL
contrast	NULL
,	NULL
the	NULL
incidence	NULL
of	NULL
constitutional	NULL
heterozygosity	NULL
reported	NULL
for	NULL
other	NULL
polymorphic	NULL
X-linked	NULL
markers	NULL
,	NULL
such	NULL
as	NULL
the	NULL
PGK	NULL
and	NULL
HPRT	NULL
loci	NULL
,	NULL
are	NULL
significantly	NULL
lower	NULL
.	NULL
``	NULL

''	NULL
In	NULL
practice	NULL
,	NULL
X-inactivation	NULL
data	NULL
may	NULL
be	NULL
corroborated	NULL
by	NULL
further	NULL
analyses	NULL
of	NULL
other	NULL
polymorphic	NULL
X-linked	NULL
loci	NULL
.	NULL

We	NULL
attempted	NULL
to	NULL
verify	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
the	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
by	NULL
PGK	NULL
analysis	NULL
,	NULL
but	NULL
the	NULL
patient	NULL
was	NULL
found	NULL
to	NULL
be	NULL
not	NULL
heterozygous	NULL
at	NULL
the	NULL
PGK	NULL
locus	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
clonality	NULL
analysis	NULL
using	NULL
X-linked	NULL
polymorphisms	NULL
is	NULL
only	NULL
useful	NULL
in	NULL
females	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
only	NULL
in	NULL
a	NULL
minority	NULL
of	NULL
patients	NULL
with	NULL
IHES	NULL
,	NULL
as	NULL
the	NULL
majority	NULL
(	NULL
approximately	NULL
90	NULL
%	NULL
)	NULL
of	NULL
these	NULL
patients	NULL
are	NULL
male	NULL
.	NULL

Eosinophil	NULL
purification	NULL
allows	NULL
HUMARA	NULL
analysis	NULL
to	NULL
be	NULL
extended	NULL
to	NULL
detect	NULL
clonal	NULL
eosinophilia	NULL
when	NULL
the	NULL
proportion	NULL
of	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
is	NULL
low	NULL
.	NULL

This	NULL
should	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
permit	NULL
detection	NULL
of	NULL
clonal	NULL
relapse	NULL
in	NULL
IHES	NULL
patients	NULL
and	NULL
facilitate	NULL
the	NULL
assessment	NULL
of	NULL
therapeutic	NULL
responses	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
to	NULL
be	NULL
noted	NULL
that	NULL
an	NULL
absence	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
by	NULL
this	NULL
method	NULL
of	NULL
analysis	NULL
can	NULL
not	NULL
completely	NULL
exclude	NULL
the	NULL
possibilty	NULL
that	NULL
a	NULL
minor	NULL
clonal	NULL
population	NULL
of	NULL
eosinophils	NULL
may	NULL
persist	NULL
.	NULL

Long-term	NULL
fol-low-up	NULL
of	NULL
our	NULL
patient	NULL
presenting	NULL
with	NULL
IHES	NULL
is	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
continued	NULL
suppression	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
by	NULL
a	NULL
low	NULL
dose	NULL
of	NULL
corticosteroids	NULL
can	NULL
be	NULL
maintained	NULL
.	NULL

Although	NULL
vasculitis	NULL
is	NULL
not	NULL
a	NULL
prominent	NULL
feature	NULL
of	NULL
IHES	NULL
,	NULL
individual	NULL
patients	NULL
with	NULL
IHES	NULL
may	NULL
exhibit	NULL
pathologic	NULL
evidence	NULL
of	NULL
vasculitis	NULL
.	NULL
``	NULL

The	NULL
major	NULL
vasculitis	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
eosinophilia	NULL
is	NULL
the	NULL
Churg-Strauss	NULL
syndrome	NULL
.	NULL
``	NULL

A	NULL
history	NULL
of	NULL
asthma	NULL
,	NULL
nonfixed	NULL
pulmonary	NULL
infiltrates	NULL
,	NULL
blood	NULL
eosinophilia	NULL
greater	NULL
than	NULL
10	NULL
%	NULL
,	NULL
paranasal	NULL
sinus	NULL
abnormalities	NULL
,	NULL
mononeuropa-thy	NULL
or	NULL
polyneuropathy	NULL
,	NULL
and	NULL
a	NULL
biopsied	NULL
blood	NULL
vessel	NULL
demonstrating	NULL
extravascular	NULL
eosinophils	NULL
are	NULL
features	NULL
of	NULL
this	NULL
syndrome	NULL
.	NULL
``	NULL

In	NULL
some	NULL
patients	NULL
,	NULL
clear	NULL
distinction	NULL
between	NULL
IHES	NULL
and	NULL
Churg-Strauss	NULL
syndrome	NULL
may	NULL
not	NULL
be	NULL
possible	NULL
.	NULL

However	NULL
,	NULL
our	NULL
patient	NULL
(	NULL
case	NULL
2	NULL
)	NULL
showed	NULL
the	NULL
characteristic	NULL
features	NULL
of	NULL
this	NULL
syndrome	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
eosinophils	NULL
were	NULL
polyclonal	NULL
in	NULL
this	NULL
patient	NULL
provides	NULL
definitive	NULL
evidence	NULL
that	NULL
eosinophilia	NULL
is	NULL
reactive	NULL
in	NULL
nature	NULL
in	NULL
the	NULL
Churg-Strauss	NULL
syndrome	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
the	NULL
underlying	NULL
pathogenesis	NULL
of	NULL
a	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
IHES	NULL
.	NULL

Eosinophilic	NULL
proliferation	NULL
and	NULL
differentiation	NULL
is	NULL
promoted	NULL
by	NULL
several	NULL
cyto-kines	NULL
,	NULL
including	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-3	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
IL-5	NULL
,	NULL
which	NULL
is	NULL
the	NULL
most	NULL
important	NULL
CHANG	NULL
ET	NULL
AL	NULL
and	NULL
,	NULL
in	NULL
humans	NULL
,	NULL
is	NULL
restricted	NULL
to	NULL
stimulating	NULL
eosinophil	NULL
produc-tion	NULL
.	NULL
``	NULL

''	NULL
Reactive	NULL
eosinophilias	NULL
such	NULL
as	NULL
infections	NULL
,	NULL
allergies	NULL
,	NULL
drug	NULL
reactions	NULL
,	NULL
skin	NULL
diseases	NULL
,	NULL
connective	NULL
tissue	NULL
diseases	NULL
,	NULL
and	NULL
malignancies	NULL
are	NULL
associated	NULL
with	NULL
eosinophilia	NULL
through	NULL
stimulation	NULL
by	NULL
IL-5	NULL
secreted	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

*©	NULL
Recently	NULL
,	NULL
there	NULL
have	NULL
been	NULL
reports	NULL
of	NULL
a	NULL
clonal	NULL
population	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
an	NULL
unusual	NULL
phenotype	NULL
,	NULL
CD3~	NULL
,	NULL
CD4*	NULL
or	NULL
CD3t+	NULL
,	NULL
CD4~	NULL
,	NULL
CD8~	NULL
,	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
several	NULL
cases	NULL
of	NULL
eosinophilia	NULL
,	NULL
including	NULL
IHES	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
In	NULL
one	NULL
report	NULL
,	NULL
``	NULL
``	NULL
a	NULL
patient	NULL
with	NULL
IHES	NULL
who	NULL
had	NULL
excessive	NULL
production	NULL
of	NULL
IgE	NULL
was	NULL
found	NULL
to	NULL
have	NULL
a	NULL
CD3~	NULL
,	NULL
CD4*	NULL
Type	NULL
2	NULL
helper	NULL
T-cell	NULL
clone	NULL
that	NULL
secreted	NULL
high	NULL
levels	NULL
of	NULL
IL-5	NULL
and	NULL
IL-4	NULL
,	NULL
which	NULL
stimulates	NULL
IgE	NULL
production	NULL
.	NULL

In	NULL
patients	NULL
with	NULL
IHES	NULL
who	NULL
have	NULL
high	NULL
levels	NULL
of	NULL
IgE	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
hypereosinophilia	NULL
may	NULL
result	NULL
from	NULL
an	NULL
IgE-mediated	NULL
hypersensitivity	NULL
response	NULL
to	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
antigen	NULL
or	NULL
antigens	NULL
.	NULL

?	NULL
``	NULL

This	NULL
subgroup	NULL
of	NULL
patients	NULL
is	NULL
characterized	NULL
by	NULL
responsiveness	NULL
to	NULL
corticosteroid	NULL
therapy	NULL
and	NULL
a	NULL
good	NULL
prognosis	NULL
,	NULL
``	NULL
as	NULL
seen	NULL
in	NULL
the	NULL
case	NULL
that	NULL
we	NULL
have	NULL
described	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
hypereosinophilia	NULL
in	NULL
these	NULL
patients	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
dysregulated	NULL
,	NULL
autonomous	NULL
replication	NULL
of	NULL
a	NULL
clonal	NULL
population	NULL
of	NULL
eosinophils	NULL
after	NULL
stimulation	NULL
by	NULL
increased	NULL
levels	NULL
of	NULL
IL-5	NULL
.	NULL

Other	NULL
hypotheses	NULL
for	NULL
the	NULL
pathogenesis	NULL
of	NULL
IHES	NULL
have	NULL
been	NULL
suggested	NULL
,	NULL
such	NULL
as	NULL
defects	NULL
in	NULL
cytokine	NULL
receptors	NULL
,	NULL
or	NULL
in	NULL
their	NULL
signal	NULL
transduction	NULL
or	NULL
suppressor	NULL
regulatory	NULL
pathways	NULL
,	NULL
``	NULL
``	NULL
``	NULL
'	NULL
but	NULL
these	NULL
remain	NULL
speculative	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
finding	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
IHES	NULL
could	NULL
imply	NULL
that	NULL
somatic	NULL
mutation	NULL
affecting	NULL
the	NULL
eosinophil	NULL
lineage	NULL
is	NULL
present	NULL
in	NULL
the	NULL
patient	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
karyotypic	NULL
abnormalities	NULL
,	NULL
and	NULL
that	NULL
the	NULL
patient	NULL
has	NULL
,	NULL
in	NULL
reality	NULL
,	NULL
a	NULL
low-grade	NULL
clonal	NULL
myeloproliferative	NULL
disorder	NULL
.	NULL

Cases	NULL
of	NULL
IHES	NULL
that	NULL
show	NULL
a	NULL
clonal	NULL
cytogenetic	NULL
abnormality	NULL
should	NULL
be	NULL
classified	NULL
as	NULL
eosinophilic	NULL
leukemia	NULL
,	NULL
``	NULL
and	NULL
it	NULL
has	NULL
been	NULL
argued	NULL
that	NULL
all	NULL
cases	NULL
of	NULL
clonal	NULL
eosinophilia	NULL
should	NULL
,	NULL
by	NULL
definition	NULL
,	NULL
be	NULL
excluded	NULL
from	NULL
IHES.°	NULL
The	NULL
method	NULL
of	NULL
analysis	NULL
that	NULL
we	NULL
have	NULL
described	NULL
would	NULL
allow	NULL
clonal	NULL
eosinophilias	NULL
to	NULL
be	NULL
distinguished	NULL
from	NULL
reactive	NULL
eosinophilias	NULL
in	NULL
female	NULL
patients	NULL
presenting	NULL
with	NULL
IHES	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
karyotypic	NULL
abnormalities	NULL
,	NULL
HUMARA	NULL
analysis	NULL
of	NULL
isolated	NULL
eosinophils	NULL
can	NULL
be	NULL
used	NULL
to	NULL
detect	NULL
clonal	NULL
eosinophilias	NULL
and	NULL
can	NULL
provide	NULL
a	NULL
marker	NULL
to	NULL
assess	NULL
disease	NULL
progression	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Fauci	NULL
AS	NULL
Harley	NULL
JB	NULL
,	NULL
Roberts	NULL
WC	NULL
,	NULL
Ferrans	NULL
VJ	NULL
,	NULL
Gralnick	NULL
HR	NULL
,	NULL
Bjornson	NULL
BH	NULL
:	NULL
NIH	NULL
Conference	NULL
.	NULL

The	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Clinical	NULL
,	NULL
pathophysiologic	NULL
,	NULL
and	NULL
therapeutic	NULL
considerations	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
97:78	NULL
,	NULL
1987	NULL
2	NULL
.	NULL

Weller	NULL
PF	NULL
,	NULL
Bubley	NULL
GJ	NULL
:	NULL
The	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Blood	NULL
83:2759	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Chusid	NULL
MJ	NULL
,	NULL
Dale	NULL
DC	NULL
,	NULL
West	NULL
BC	NULL
,	NULL
Wolff	NULL
SM	NULL
:	NULL
The	NULL
hypereosinophilic	NULL
syndrome	NULL
:	NULL
Analysis	NULL
of	NULL
fourteen	NULL
cases	NULL
with	NULL
review	NULL
of	NULL
the	NULL
literature	NULL
.	NULL

Medicine	NULL
(	NULL
Baltimore	NULL
)	NULL
54:1	NULL
,	NULL
1975	NULL
4	NULL
.	NULL

Lefebvre	NULL
C	NULL
,	NULL
Bletry	NULL
O	NULL
,	NULL
Degoulet	NULL
P	NULL
,	NULL
Guillevin	NULL
L	NULL
,	NULL
Bentata-Pesyre	NULL
M	NULL
,	NULL
Le	NULL
Thi	NULL
HD	NULL
,	NULL
Godeau	NULL
P	NULL
:	NULL
Facteurs	NULL
pronostiques	NULL
du	NULL
syndrome	NULL
hyperéosino-philique	NULL
.	NULL

Etude	NULL
de	NULL
40	NULL
observations	NULL
.	NULL

Ann	NULL
Med	NULL
Interne	NULL
(	NULL
Paris	NULL
)	NULL
140:253	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Schooley	NULL
RT	NULL
,	NULL
Flaum	NULL
MA	NULL
,	NULL
Gralnick	NULL
HR	NULL
,	NULL
Fauci	NULL
AS	NULL
:	NULL
A	NULL
clinico-pathologic	NULL
correlation	NULL
of	NULL
the	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

II	NULL
.	NULL

Clinical	NULL
manifestations	NULL
.	NULL

Blood	NULL
58:1021	NULL
,	NULL
1981	NULL
6	NULL
.	NULL

Brito-Babapulle	NULL
F	NULL
:	NULL
Clonal	NULL
eosinophilic	NULL
disorders	NULL
and	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Blood	NULL
Rev	NULL
11:129	NULL
,	NULL
1997	NULL
7	NULL
.	NULL

Vogelstein	NULL
B	NULL
,	NULL
Fearon	NULL
ER	NULL
,	NULL
Hamilton	NULL
SR	NULL
,	NULL
Preisinger	NULL
AC	NULL
,	NULL
Willard	NULL
HF	NULL
,	NULL
Michelson	NULL
AM	NULL
,	NULL
Riggs	NULL
AD	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Clonal	NULL
analysis	NULL
using	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EOSINOPHIL	NULL
CLONALITY	NULL
IN	NULL
IHES	NULL
recombinant	NULL
DNA	NULL
probes	NULL
from	NULL
the	NULL
X-chromosome	NULL
.	NULL

Cancer	NULL
Res	NULL
47	NULL
:	NULL
4806	NULL
,	NULL
1987	NULL
8	NULL
.	NULL

Boyd	NULL
Y	NULL
,	NULL
Fraser	NULL
NJ	NULL
:	NULL
Methylation	NULL
patterns	NULL
at	NULL
the	NULL
hypervariable	NULL
X-chromosome	NULL
locus	NULL
DXS255	NULL
(	NULL
M27B	NULL
)	NULL
:	NULL
Correlation	NULL
with	NULL
X-inactivation	NULL
status	NULL
.	NULL

Genomics	NULL
7:182	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Allen	NULL
CR	NULL
,	NULL
Zoghbi	NULL
HY	NULL
,	NULL
Moseley	NULL
AB	NULL
,	NULL
Rosenblatt	NULL
HM	NULL
,	NULL
Belmont	NULL
JW	NULL
:	NULL
Methylation	NULL
of	NULL
Hpall	NULL
and	NULL
Hhal	NULL
sites	NULL
near	NULL
the	NULL
polymorphic	NULL
CAG	NULL
repeat	NULL
in	NULL
the	NULL
human	NULL
androgen	NULL
receptor	NULL
gene	NULL
correlates	NULL
with	NULL
X-chromosome	NULL
inactivation	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
51:1229	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Gale	NULL
RE	NULL
,	NULL
Wainscoat	NULL
JS	NULL
:	NULL
Clonal	NULL
analysis	NULL
using	NULL
X-linked	NULL
DNA	NULL
polymorphisms	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
85:2	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Lyon	NULL
MF	NULL
:	NULL
X-chromosome	NULL
inactivation	NULL
and	NULL
developmental	NULL
patterns	NULL
in	NULL
mammals	NULL
.	NULL

Biol	NULL
Rev	NULL
Camb	NULL
Philos	NULL
Soc	NULL
47:1	NULL
,	NULL
1972	NULL
12	NULL
.	NULL

Riggs	NULL
AD	NULL
:	NULL
X-inactivation	NULL
,	NULL
differentiation	NULL
and	NULL
DNA-methylation	NULL
.	NULL

Cytogenet	NULL
Cell	NULL
Genet	NULL
14:9	NULL
,	NULL
1975	NULL
13	NULL
.	NULL

Martin	NULL
GR	NULL
,	NULL
Epstein	NULL
CJ	NULL
,	NULL
Travis	NULL
B	NULL
,	NULL
Tucker	NULL
G	NULL
,	NULL
Yatziv	NULL
S	NULL
,	NULL
Martin	NULL
DW	NULL
Jr	NULL
,	NULL
Clift	NULL
C	NULL
,	NULL
Cohen	NULL
S	NULL
:	NULL
X-chromosome	NULL
inactivation	NULL
during	NULL
differentiation	NULL
of	NULL
female	NULL
teratocarcinoma	NULL
stem	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Nature	NULL
271:329	NULL
,	NULL
1978	NULL
14	NULL
.	NULL

Lyon	NULL
MF	NULL
:	NULL
X-chromosome	NULL
inactivation	NULL
and	NULL
the	NULL
location	NULL
and	NULL
expression	NULL
of	NULL
X-linked	NULL
genes	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
42:8	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Busque	NULL
L	NULL
,	NULL
Gilliland	NULL
G	NULL
:	NULL
Clonal	NULL
evolution	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
82:337	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Luppi	NULL
M	NULL
,	NULL
Marasca	NULL
R	NULL
,	NULL
Morselli	NULL
M	NULL
,	NULL
Barozzi	NULL
P	NULL
,	NULL
Torelli	NULL
G	NULL
:	NULL
Clonal	NULL
nature	NULL
of	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Blood	NULL
84:349	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Gale	NULL
RE	NULL
,	NULL
Mein	NULL
CA	NULL
,	NULL
Linch	NULL
DC	NULL
:	NULL
Quantification	NULL
of	NULL
X-chromosome	NULL
inactivation	NULL
patterns	NULL
in	NULL
haematological	NULL
samples	NULL
using	NULL
the	NULL
DNA	NULL
PCR-based	NULL
HUMARA	NULL
assay	NULL
.	NULL

Leukemia	NULL
10:362	NULL
,	NULL
1996	NULL
18	NULL
.	NULL

Weil	NULL
GJ	NULL
,	NULL
Chused	NULL
TM	NULL
:	NULL
Eosinophil	NULL
autofluorescence	NULL
and	NULL
its	NULL
use	NULL
in	NULL
isolation	NULL
and	NULL
analysis	NULL
of	NULL
human	NULL
eosinophils	NULL
using	NULL
flow	NULL
microfluorom-etry	NULL
.	NULL

Blood	NULL
57:1099	NULL
,	NULL
1981	NULL
19	NULL
.	NULL

Mayeno	NULL
AN	NULL
,	NULL
Hamann	NULL
KJ	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
Granule-associated	NULL
flavin	NULL
adenine	NULL
dinucleotide	NULL
(	NULL
FAD	NULL
)	NULL
is	NULL
responsible	NULL
for	NULL
eosinophil	NULL
autofluores-cence	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
51:172	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Maniatis	NULL
T	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Sambrook	NULL
J	NULL
:	NULL
Molecular	NULL
cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1988	NULL
1657	NULL
21	NULL
.	NULL

Anan	NULL
K	NULL
,	NULL
Ito	NULL
M	NULL
,	NULL
Misawa	NULL
M	NULL
,	NULL
Ohe	NULL
Y	NULL
,	NULL
Kai	NULL
S	NULL
,	NULL
Kohsaki	NULL
M	NULL
:	NULL
Clonal	NULL
analysis	NULL
of	NULL
peripheral	NULL
blood	NULL
and	NULL
haemopoietic	NULL
colonies	NULL
in	NULL
patients	NULL
with	NULL
aplastic	NULL
anaemia	NULL
and	NULL
refractory	NULL
anaemia	NULL
using	NULL
polymorphic	NULL
short	NULL
tandem	NULL
repeat	NULL
on	NULL
the	NULL
HUMARA	NULL
gene	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
89:839	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Gilliland	NULL
DG	NULL
,	NULL
Blanchard	NULL
KL	NULL
,	NULL
Levy	NULL
J	NULL
,	NULL
Perrin	NULL
S	NULL
,	NULL
Bunn	NULL
HF	NULL
:	NULL
Clonality	NULL
in	NULL
myeloproliferative	NULL
disorders	NULL
:	NULL
Analysis	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:6848	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Churg	NULL
J	NULL
,	NULL
Strauss	NULL
L	NULL
:	NULL
Allergic	NULL
granulomatosis	NULL
,	NULL
allergic	NULL
angiitis	NULL
and	NULL
periarteritis	NULL
nodosa	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
27:277	NULL
,	NULL
1951	NULL
24	NULL
.	NULL

Masi	NULL
AT	NULL
,	NULL
Hunder	NULL
GG	NULL
,	NULL
Lie	NULL
JT	NULL
,	NULL
Michael	NULL
BA	NULL
,	NULL
Bloch	NULL
DA	NULL
,	NULL
Arend	NULL
WP	NULL
,	NULL
Calabrese	NULL
LH	NULL
,	NULL
Edworthy	NULL
SM	NULL
,	NULL
Fauci	NULL
AS	NULL
,	NULL
Leavitt	NULL
RY	NULL
,	NULL
Lightfoot	NULL
RWJ	NULL
,	NULL
McShane	NULL
DJ	NULL
,	NULL
Mills	NULL
JA	NULL
,	NULL
Stevens	NULL
MB	NULL
,	NULL
Wallace	NULL
SL	NULL
,	NULL
Zvaifler	NULL
NJ	NULL
:	NULL
The	NULL
American	NULL
College	NULL
of	NULL
Rheumatology	NULL
1990	NULL
criteria	NULL
for	NULL
the	NULL
classification	NULL
of	NULL
Churg-Strauss	NULL
syndrome	NULL
(	NULL
allergic	NULL
granulomatosis	NULL
and	NULL
angiitis	NULL
)	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
33:1094	NULL
,	NULL
1990	NULL
25	NULL
.	NULL

Parillo	NULL
JE	NULL
,	NULL
Lawley	NULL
TJ	NULL
,	NULL
Frank	NULL
MM	NULL
,	NULL
Kaplan	NULL
AP	NULL
,	NULL
Fauci	NULL
AS	NULL
:	NULL
Immunologic	NULL
reactivity	NULL
in	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
64:113	NULL
,	NULL
1979	NULL
26	NULL
.	NULL

Parillo	NULL
JE	NULL
,	NULL
Fauci	NULL
AS	NULL
,	NULL
Wolff	NULL
SM	NULL
:	NULL
Therapy	NULL
of	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
89:167	NULL
,	NULL
1978	NULL
27	NULL
.	NULL

Sanderson	NULL
CJ	NULL
:	NULL
Interleukin	NULL
5	NULL
,	NULL
eosinophils	NULL
and	NULL
disease	NULL
.	NULL

Blood	NULL
79:3101	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Cogan	NULL
E	NULL
,	NULL
Schandené	NULL
L	NULL
,	NULL
Crusiaux	NULL
A	NULL
,	NULL
Cochaux	NULL
P	NULL
,	NULL
Velu	NULL
T	NULL
,	NULL
Goldman	NULL
M	NULL
:	NULL
Clonal	NULL
proliferation	NULL
of	NULL
type	NULL
2	NULL
helper	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
man	NULL
with	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
330:535	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Kitano	NULL
K	NULL
,	NULL
Ichikawa	NULL
N	NULL
,	NULL
Shimodaira	NULL
S	NULL
,	NULL
Ito	NULL
T	NULL
,	NULL
Ishida	NULL
F	NULL
,	NULL
Kiyosawa	NULL
K	NULL
:	NULL
Eosinophilia	NULL
associated	NULL
with	NULL
clonal	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Leuk	NULL
Lymphoma	NULL
27:335	NULL
,	NULL
1997	NULL
30	NULL
.	NULL

Spry	NULL
CJF	NULL
:	NULL
Idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
,	NULL
in	NULL
Makino	NULL
T	NULL
,	NULL
Fukuda	NULL
S	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Eosinophils	NULL
:	NULL
Biological	NULL
and	NULL
Clinical	NULL
Aspects	NULL
.	NULL

Boca	NULL
Raton	NULL
,	NULL
FL	NULL
,	NULL
CRC	NULL
,	NULL
1992	NULL
,	NULL
p	NULL
403	NULL
31	NULL
.	NULL

Weller	NULL
PF	NULL
,	NULL
Goetze	NULL
EJ	NULL
:	NULL
The	NULL
regulatory	NULL
and	NULL
effector	NULL
roles	NULL
of	NULL
eosinophils	NULL
.	NULL

Adv	NULL
Immunol	NULL
27:339	NULL
,	NULL
1979	NULL
32	NULL
.	NULL

Bain	NULL
BJ	NULL
:	NULL
Eosinophilic	NULL
leukaemias	NULL
and	NULL
the	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
95:2	NULL
,	NULL
1996	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GUY	NULL
o	NULL
;	NULL
.	NULL

4	NULL
95	NULL
00	NULL
1999	NULL
93	NULL
:	NULL
1651-1657	NULL
¥®	NULL
Clonality	NULL
of	NULL
Isolated	NULL
Eosinophils	NULL
in	NULL
the	NULL
Hypereosinophilic	NULL
Syndrome	NULL
“	NULL
New	NULL
Ow	NULL
Hsiao-Wen	NULL
Chang	NULL
,	NULL
Kah-Hoo	NULL
Leong	NULL
,	NULL
Dow-Rhoon	NULL
Koh	NULL
and	NULL
Szu-Hee	NULL
Lee	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

